Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Ramlau

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
British Journal of Cancer|April 28, 2006
Docetaxel-based induction therapy prior to radiotherapy with or without docetaxel for non-small-cell lung cancerG V Scagliotti, A Szczesna, R Ramlau, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 13, 2010
Overall survival with cisplatin-gemcitabine and bevacizumab or placebo as first-line therapy for nonsquamous non-small-cell lung cancer: results from a randomised phase III trial (AVAiL)M Reck, J von Pawel, P Zatloukal, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 5, 2002
A multicenter randomized phase II study of oral vs. intravenous vinorelbine in advanced non-small-cell lung cancer patientsJ Jassem, R Ramlau, H Karnicka-Młodkowska, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 15, 2002
Oral vinorelbine: feasibility and safety profileA Depierre, G Freyer, J Jassem, et al.
Inorganic Chemistry|May 1, 2013
Structure and magnetic properties of Cu3Ni2SbO6 and Cu3Co2SbO6 Delafossites with honeycomb latticesJ H Roudebush, N H Andersen, R Ramlau, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 29, 2003
Oral vinorelbine in combination with cisplatin: a novel active regimen in advanced non-small-cell lung cancerJ Jassem, P Kosmidis, R Ramlau, et al.
Lung Cancer (Amsterdam, Netherlands)|March 22, 2005
Phase II trial of oral vinorelbine in combination with cisplatin followed by consolidation therapy with oral vinorelbine in advanced NSCLCM De Lena, R Ramlau, O Hansen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2000
Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapyF A Shepherd, J Dancey, R Ramlau, et al.
Lung Cancer (Amsterdam, Netherlands)|April 14, 2012
Prognostic factors in patients with advanced non-small cell lung cancer: data from the phase III FLEX studyR Pirker, J R Pereira, A Szczesna, et al.
ESMO Open|February 21, 2021
Metronomic oral vinorelbine in previously untreated advanced non-small-cell lung cancer patients unfit for platinum-based chemotherapy: results of the randomized phase II Tempo Lung trialA Camerini, A Morabito, A Montanino, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
British Journal of Cancer|April 28, 2006
Docetaxel-based induction therapy prior to radiotherapy with or without docetaxel for non-small-cell lung cancerG V Scagliotti, A Szczesna, R Ramlau, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 13, 2010
Overall survival with cisplatin-gemcitabine and bevacizumab or placebo as first-line therapy for nonsquamous non-small-cell lung cancer: results from a randomised phase III trial (AVAiL)M Reck, J von Pawel, P Zatloukal, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 5, 2002
A multicenter randomized phase II study of oral vs. intravenous vinorelbine in advanced non-small-cell lung cancer patientsJ Jassem, R Ramlau, H Karnicka-Młodkowska, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 15, 2002
Oral vinorelbine: feasibility and safety profileA Depierre, G Freyer, J Jassem, et al.
Inorganic Chemistry|May 1, 2013
Structure and magnetic properties of Cu3Ni2SbO6 and Cu3Co2SbO6 Delafossites with honeycomb latticesJ H Roudebush, N H Andersen, R Ramlau, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 29, 2003
Oral vinorelbine in combination with cisplatin: a novel active regimen in advanced non-small-cell lung cancerJ Jassem, P Kosmidis, R Ramlau, et al.
Lung Cancer (Amsterdam, Netherlands)|March 22, 2005
Phase II trial of oral vinorelbine in combination with cisplatin followed by consolidation therapy with oral vinorelbine in advanced NSCLCM De Lena, R Ramlau, O Hansen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2000
Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapyF A Shepherd, J Dancey, R Ramlau, et al.
Lung Cancer (Amsterdam, Netherlands)|April 14, 2012
Prognostic factors in patients with advanced non-small cell lung cancer: data from the phase III FLEX studyR Pirker, J R Pereira, A Szczesna, et al.
ESMO Open|February 21, 2021
Metronomic oral vinorelbine in previously untreated advanced non-small-cell lung cancer patients unfit for platinum-based chemotherapy: results of the randomized phase II Tempo Lung trialA Camerini, A Morabito, A Montanino, et al.
Pageof 3